153 related articles for article (PubMed ID: 35063646)
1. DNMT3A facilitates colorectal cancer progression via regulating DAB2IP mediated MEK/ERK activation.
Zhou Y; Yang Z; Zhang H; Li H; Zhang M; Wang H; Zhang M; Qiu P; Zhang R; Liu J
Biochim Biophys Acta Mol Basis Dis; 2022 Apr; 1868(4):166353. PubMed ID: 35063646
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor miR-193a-3p enhances efficacy of BRAF/MEK inhibitors in BRAF-mutated colorectal cancer.
Hiraide S; Takahashi M; Yoshida Y; Yamada H; Komine K; Ishioka C
Cancer Sci; 2021 Sep; 112(9):3856-3870. PubMed ID: 34288281
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-889 promotes cell proliferation in colorectal cancer by targeting DAB2IP.
Xiao Y; Li ZH; Bi YH
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3326-3334. PubMed ID: 31081086
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of DAB2IP promotes colorectal cancer invasion and metastasis by translocating hnRNPK into nucleus to enhance the transcription of MMP2.
Zhu XH; Wang JM; Yang SS; Wang FF; Hu JL; Xin SN; Men H; Lu GF; Lan XL; Zhang D; Wang XY; Liao WT; Ding YQ; Liang L
Int J Cancer; 2017 Jul; 141(1):172-183. PubMed ID: 28335083
[TBL] [Abstract][Full Text] [Related]
5. Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer.
Min J; Liu L; Li X; Jiang J; Wang J; Zhang B; Cao D; Yu D; Tao D; Hu J; Gong J; Xie D
Sci Rep; 2015 Nov; 5():16578. PubMed ID: 26564738
[TBL] [Abstract][Full Text] [Related]
6. Relationships among
Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX
World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081
[TBL] [Abstract][Full Text] [Related]
7. Silencing of linc00337 inhibits proliferation, cell cycle progression, migration, and invasion of colorectal cancer cells through the MEK/ERK pathway.
Wang ZG; Yang YG; Fu GS; Lu DH; Tian SY; Wei W
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5353-5359. PubMed ID: 32495869
[TBL] [Abstract][Full Text] [Related]
8. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer.
Ye Q; Cai W; Zheng Y; Evers BM; She QB
Oncogene; 2014 Apr; 33(14):1828-39. PubMed ID: 23624914
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer.
Shen YJ; Kong ZL; Wan FN; Wang HK; Bian XJ; Gan HL; Wang CF; Ye DW
Cancer Sci; 2014 Jun; 105(6):704-12. PubMed ID: 24684735
[TBL] [Abstract][Full Text] [Related]
10. miR-182 contributes to cell proliferation, invasion and tumor growth in colorectal cancer by targeting DAB2IP.
Li X; Zhang X; Zhang Q; Lin R
Int J Biochem Cell Biol; 2019 Jun; 111():27-36. PubMed ID: 30974224
[TBL] [Abstract][Full Text] [Related]
11. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
Wang B; Gu Q; Li J
Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
[TBL] [Abstract][Full Text] [Related]
12. The positive feedback between Snail and DAB2IP regulates EMT, invasion and metastasis in colorectal cancer.
Wang J; Zhu X; Hu J; He G; Li X; Wu P; Ren X; Wang F; Liao W; Liang L; Ding Y
Oncotarget; 2015 Sep; 6(29):27427-39. PubMed ID: 26336990
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of DAB2IP Inhibits Ras Activity and Tumorigenesis in Human Pancreatic Cancer Cells.
Duan Y; Yin X; Lai X; Liu C; Nie W; Li D; Xie Z; Li Z; Meng F
Technol Cancer Res Treat; 2020; 19():1533033819895494. PubMed ID: 32336215
[TBL] [Abstract][Full Text] [Related]
14. DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitor.
Yu L; Tumati V; Tseng SF; Hsu FM; Kim DN; Hong D; Hsieh JT; Jacobs C; Kapur P; Saha D
Neoplasia; 2012 Dec; 14(12):1203-12. PubMed ID: 23308052
[TBL] [Abstract][Full Text] [Related]
15. DAB2IP in cancer.
Liu L; Xu C; Hsieh JT; Gong J; Xie D
Oncotarget; 2016 Jan; 7(4):3766-76. PubMed ID: 26658103
[TBL] [Abstract][Full Text] [Related]
16. Dnmt3a is downregulated by Stat5a and mediates G0/G1 arrest by suppressing the miR-17-5p/Cdkn1a axis in Jak2
Zhou J; Guo C; Wu H; Li B; Zhou LL; Liang AB; Fu JF
BMC Cancer; 2021 Nov; 21(1):1213. PubMed ID: 34773997
[TBL] [Abstract][Full Text] [Related]
17. DAB2IP decreases cell growth and migration and increases sensitivity to chemotherapeutic drugs in colorectal cancer.
Wu G; Xu X; Wan D; Zhou D; Feng Y; Chen J; Peng Z; Fang D; Shi X; Yao H; Chen G; Sun L; Yao Y; Zhou G; Yang Y; He S
Ann Transl Med; 2021 Aug; 9(16):1317. PubMed ID: 34532454
[TBL] [Abstract][Full Text] [Related]
18. DAB2IP down-regulates HSP90AA1 to inhibit the malignant biological behaviors of colorectal cancer.
Zhang M; Peng Y; Yang Z; Zhang H; Xu C; Liu L; Zhao Q; Wu J; Wang H; Liu J
BMC Cancer; 2022 May; 22(1):561. PubMed ID: 35590292
[TBL] [Abstract][Full Text] [Related]
19. miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
Feng C; Sun P; Hu J; Feng H; Li M; Liu G; Pan Y; Feng Y; Xu Y; Feng K; Feng Y
Int J Oncol; 2017 Jun; 50(6):2101-2112. PubMed ID: 28440444
[TBL] [Abstract][Full Text] [Related]
20. The sodium channel subunit SCNN1B suppresses colorectal cancer via suppression of active c-Raf and MAPK signaling cascade.
Qian Y; Zhou L; Luk STY; Xu J; Li W; Gou H; Chen H; Kang W; Yu J; Wong CC
Oncogene; 2023 Feb; 42(8):601-612. PubMed ID: 36564468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]